

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 9.43508712 |
| 2 | protein heterotrimerization (GO:0070208) | 9.27449030 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 9.00910685 |
| 4 | triglyceride catabolic process (GO:0019433) | 8.40642511 |
| 5 | collagen fibril organization (GO:0030199) | 8.39856921 |
| 6 | acylglycerol catabolic process (GO:0046464) | 7.39948599 |
| 7 | neutral lipid catabolic process (GO:0046461) | 7.39948599 |
| 8 | bone trabecula formation (GO:0060346) | 7.24983210 |
| 9 | sequestering of extracellular ligand from receptor (GO:0035581) | 6.35420798 |
| 10 | response to dietary excess (GO:0002021) | 6.29852279 |
| 11 | skin morphogenesis (GO:0043589) | 6.19163317 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 6.17737125 |
| 13 | chondrocyte proliferation (GO:0035988) | 5.89942703 |
| 14 | extracellular matrix assembly (GO:0085029) | 5.82782868 |
| 15 | transcytosis (GO:0045056) | 5.54904207 |
| 16 | glycerolipid catabolic process (GO:0046503) | 5.36235406 |
| 17 | collagen metabolic process (GO:0032963) | 5.30080809 |
| 18 | glomerular filtration (GO:0003094) | 5.29511684 |
| 19 | collagen catabolic process (GO:0030574) | 5.22089900 |
| 20 | endodermal cell differentiation (GO:0035987) | 5.21602276 |
| 21 | fatty acid homeostasis (GO:0055089) | 5.12369703 |
| 22 | positive regulation of glomerulus development (GO:0090193) | 4.99459848 |
| 23 | multicellular organismal macromolecule metabolic process (GO:0044259) | 4.96025414 |
| 24 | extracellular fibril organization (GO:0043206) | 4.95338857 |
| 25 | chondrocyte development (GO:0002063) | 4.93215094 |
| 26 | multicellular organismal catabolic process (GO:0044243) | 4.79421830 |
| 27 | ovulation from ovarian follicle (GO:0001542) | 4.69256398 |
| 28 | multicellular organismal metabolic process (GO:0044236) | 4.67277354 |
| 29 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.67242380 |
| 30 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 4.66473986 |
| 31 | regulation of gonadotropin secretion (GO:0032276) | 4.60161359 |
| 32 | renal filtration (GO:0097205) | 4.58734070 |
| 33 | negative regulation of macrophage differentiation (GO:0045650) | 4.54267346 |
| 34 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.52310467 |
| 35 | fibril organization (GO:0097435) | 4.50500270 |
| 36 | myoblast migration (GO:0051451) | 4.50447410 |
| 37 | lipid particle organization (GO:0034389) | 4.48814517 |
| 38 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.40814055 |
| 39 | white fat cell differentiation (GO:0050872) | 4.38294099 |
| 40 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 4.37952828 |
| 41 | diacylglycerol metabolic process (GO:0046339) | 4.37804689 |
| 42 | NADH metabolic process (GO:0006734) | 4.36862505 |
| 43 | epithelial cell-cell adhesion (GO:0090136) | 4.35975003 |
| 44 | brown fat cell differentiation (GO:0050873) | 4.33144027 |
| 45 | negative regulation of amino acid transport (GO:0051956) | 4.30048971 |
| 46 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.29166077 |
| 47 | extracellular matrix disassembly (GO:0022617) | 4.26289085 |
| 48 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.25427147 |
| 49 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.23182199 |
| 50 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.18889939 |
| 51 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.15511619 |
| 52 | lipid storage (GO:0019915) | 4.10611646 |
| 53 | peptidyl-proline hydroxylation (GO:0019511) | 4.07884338 |
| 54 | polyol transport (GO:0015791) | 4.06804521 |
| 55 | craniofacial suture morphogenesis (GO:0097094) | 4.00952088 |
| 56 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.99429716 |
| 57 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.97659974 |
| 58 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.97632512 |
| 59 | cGMP-mediated signaling (GO:0019934) | 3.96813966 |
| 60 | negative regulation of granulocyte differentiation (GO:0030853) | 3.96035470 |
| 61 | cell adhesion mediated by integrin (GO:0033627) | 3.95962925 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 3.93083089 |
| 63 | negative regulation of response to food (GO:0032096) | 3.91772705 |
| 64 | negative regulation of appetite (GO:0032099) | 3.91772705 |
| 65 | dermatan sulfate biosynthetic process (GO:0030208) | 3.91732390 |
| 66 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.90879493 |
| 67 | axon extension involved in axon guidance (GO:0048846) | 3.90879493 |
| 68 | cellular response to epinephrine stimulus (GO:0071872) | 3.90480354 |
| 69 | keratan sulfate biosynthetic process (GO:0018146) | 3.83253631 |
| 70 | positive regulation of catenin import into nucleus (GO:0035413) | 3.80253934 |
| 71 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.78408292 |
| 72 | protein localization to cell surface (GO:0034394) | 3.78266091 |
| 73 | paraxial mesoderm development (GO:0048339) | 3.77386803 |
| 74 | adhesion of symbiont to host cell (GO:0044650) | 3.76360085 |
| 75 | virion attachment to host cell (GO:0019062) | 3.76360085 |
| 76 | negative regulation of cell fate specification (GO:0009996) | 3.73429638 |
| 77 | endocrine hormone secretion (GO:0060986) | 3.73077605 |
| 78 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.73022340 |
| 79 | negative regulation of JUN kinase activity (GO:0043508) | 3.67490490 |
| 80 | non-canonical Wnt signaling pathway (GO:0035567) | 3.63958945 |
| 81 | negative regulation of embryonic development (GO:0045992) | 3.62193719 |
| 82 | extracellular matrix organization (GO:0030198) | 3.61717864 |
| 83 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.60902364 |
| 84 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.60837642 |
| 85 | cellular response to leptin stimulus (GO:0044320) | 3.60679403 |
| 86 | extracellular structure organization (GO:0043062) | 3.60297821 |
| 87 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.59999249 |
| 88 | regulation of lipoprotein metabolic process (GO:0050746) | 3.58710402 |
| 89 | regulation of cholesterol storage (GO:0010885) | 3.58441571 |
| 90 | adult feeding behavior (GO:0008343) | 3.57042525 |
| 91 | dermatan sulfate metabolic process (GO:0030205) | 3.56668010 |
| 92 | extracellular negative regulation of signal transduction (GO:1900116) | 3.53983701 |
| 93 | extracellular regulation of signal transduction (GO:1900115) | 3.53983701 |
| 94 | skeletal muscle adaptation (GO:0043501) | 3.52887753 |
| 95 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.52783266 |
| 96 | protein trimerization (GO:0070206) | 3.52630825 |
| 97 | peripheral nervous system axon ensheathment (GO:0032292) | 3.52061350 |
| 98 | myelination in peripheral nervous system (GO:0022011) | 3.52061350 |
| 99 | muscle cell migration (GO:0014812) | 3.49187896 |
| 100 | cellular response to vitamin (GO:0071295) | 3.48160275 |
| 101 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.46425044 |
| 102 | camera-type eye morphogenesis (GO:0048593) | 3.46052157 |
| 103 | cellular response to vitamin D (GO:0071305) | 3.45620645 |
| 104 | triglyceride biosynthetic process (GO:0019432) | 3.44970920 |
| 105 | response to vitamin E (GO:0033197) | 3.44503110 |
| 106 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.43402824 |
| 107 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.38879016 |
| 108 | glycerol metabolic process (GO:0006071) | 3.38447395 |
| 109 | keratan sulfate metabolic process (GO:0042339) | 3.38363884 |
| 110 | cranial suture morphogenesis (GO:0060363) | 3.38116340 |
| 111 | cornea development in camera-type eye (GO:0061303) | 3.36124867 |
| 112 | triglyceride metabolic process (GO:0006641) | 3.36115463 |
| 113 | convergent extension (GO:0060026) | 3.35923873 |
| 114 | bone morphogenesis (GO:0060349) | 3.35458967 |
| 115 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.34940894 |
| 116 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.31391365 |
| 117 | positive regulation of glucose import (GO:0046326) | 3.31273874 |
| 118 | kidney mesenchyme development (GO:0072074) | 3.30328818 |
| 119 | phagocytosis, recognition (GO:0006910) | 3.29367332 |
| 120 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.29304647 |
| 121 | protein hydroxylation (GO:0018126) | 3.28577153 |
| 122 | middle ear morphogenesis (GO:0042474) | 3.26909680 |
| 123 | retinol metabolic process (GO:0042572) | 3.26351521 |
| 124 | neutral lipid biosynthetic process (GO:0046460) | 3.24864610 |
| 125 | acylglycerol biosynthetic process (GO:0046463) | 3.24864610 |
| 126 | response to epinephrine (GO:0071871) | 3.24395319 |
| 127 | regulation of glomerulus development (GO:0090192) | 3.23497741 |
| 128 | negative regulation of cartilage development (GO:0061037) | 3.23347958 |
| 129 | glycosaminoglycan catabolic process (GO:0006027) | 3.22628684 |
| 130 | regulation of plasminogen activation (GO:0010755) | 3.21875508 |
| 131 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.20986721 |
| 132 | regulation of extracellular matrix disassembly (GO:0010715) | 3.20433689 |
| 133 | cellular response to amino acid stimulus (GO:0071230) | 3.20307196 |
| 134 | primary alcohol metabolic process (GO:0034308) | 3.20241045 |
| 135 | regulation of establishment of planar polarity (GO:0090175) | 3.19469509 |
| 136 | wound healing, spreading of epidermal cells (GO:0035313) | 3.18802946 |
| 137 | metanephric mesenchyme development (GO:0072075) | 3.18480288 |
| 138 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.17524742 |
| 139 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.17064978 |
| 140 | regulation of catenin import into nucleus (GO:0035412) | 3.14926805 |
| 141 | negative regulation of gluconeogenesis (GO:0045721) | 3.13516662 |
| 142 | substrate-dependent cell migration (GO:0006929) | 3.13068539 |
| 143 | response to leptin (GO:0044321) | 3.12210960 |
| 144 | blood vessel maturation (GO:0001955) | 3.10671634 |
| 145 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.09346208 |
| 146 | response to phenylpropanoid (GO:0080184) | 3.08078990 |
| 147 | negative regulation of fatty acid transport (GO:2000192) | 3.07986426 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 3.07648760 |
| 149 | negative regulation of BMP signaling pathway (GO:0030514) | 3.06797041 |
| 150 | negative regulation of phagocytosis (GO:0050765) | 3.05774112 |
| 151 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.05472121 |
| 152 | negative regulation of norepinephrine secretion (GO:0010700) | 3.04775233 |
| 153 | positive regulation of metanephros development (GO:0072216) | 3.04752946 |
| 154 | acylglycerol metabolic process (GO:0006639) | 3.04726441 |
| 155 | response to nitrosative stress (GO:0051409) | 3.04651869 |
| 156 | negative regulation of metanephros development (GO:0072217) | 3.04235526 |
| 157 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.03549088 |
| 158 | sulfur compound catabolic process (GO:0044273) | 3.03126723 |
| 159 | positive regulation of extracellular matrix organization (GO:1903055) | 3.02624364 |
| 160 | outer ear morphogenesis (GO:0042473) | 3.02466741 |
| 161 | glomerular basement membrane development (GO:0032836) | 3.02003803 |
| 162 | biotin metabolic process (GO:0006768) | 3.00206300 |
| 163 | neutral lipid metabolic process (GO:0006638) | 3.00175397 |
| 164 | positive regulation of cholesterol efflux (GO:0010875) | 3.00155889 |
| 165 | ossification (GO:0001503) | 2.99960314 |
| 166 | positive regulation of lipid storage (GO:0010884) | 2.99101376 |
| 167 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.97384523 |
| 168 | aminoglycan catabolic process (GO:0006026) | 2.97374198 |
| 169 | basement membrane organization (GO:0071711) | 2.96034628 |
| 170 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.95842945 |
| 171 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.95819106 |
| 172 | negative regulation of organic acid transport (GO:0032891) | 2.94837344 |
| 173 | cellular response to lithium ion (GO:0071285) | 2.94331996 |
| 174 | ethanol oxidation (GO:0006069) | 2.92749998 |
| 175 | alditol metabolic process (GO:0019400) | 2.92744190 |
| 176 | fatty acid transmembrane transport (GO:1902001) | 2.92524253 |
| 177 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.91565463 |
| 178 | tooth mineralization (GO:0034505) | 2.91368767 |
| 179 | adhesion of symbiont to host (GO:0044406) | 2.91197913 |
| 180 | negative regulation of catenin import into nucleus (GO:0035414) | 2.91045682 |
| 181 | negative regulation of protein autophosphorylation (GO:0031953) | 2.90429115 |
| 182 | cell migration involved in heart development (GO:0060973) | 2.89538080 |
| 183 | oxaloacetate metabolic process (GO:0006107) | 2.88372953 |
| 184 | negative regulation of stress fiber assembly (GO:0051497) | 2.86701384 |
| 185 | positive regulation of glycolytic process (GO:0045821) | 2.82048881 |
| 186 | regulation of gastrulation (GO:0010470) | 2.78950550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.78694207 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.65059941 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 4.16342591 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.75410651 |
| 5 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 3.06754716 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.01720520 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.01056191 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.97360825 |
| 9 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.80043950 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.70761315 |
| 11 | CJUN_26792858_Chip-Seq_BT549_Human | 2.64489071 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.63703771 |
| 13 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.62643236 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56061137 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39496874 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29822966 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29822966 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23400626 |
| 19 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.21262463 |
| 20 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.21262463 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18836481 |
| 22 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.18289446 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16484299 |
| 24 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.15153734 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12620188 |
| 26 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.10306496 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06028011 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.05457010 |
| 29 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.04780502 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04344641 |
| 31 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.04306280 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.1582742 |
| 33 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.97494086 |
| 34 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.97494086 |
| 35 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.97494086 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96634640 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92906585 |
| 38 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.91336022 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87281631 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76831692 |
| 41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.76306222 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.75964191 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70471051 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69314814 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.66259254 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63674487 |
| 47 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.63657150 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62863502 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61186371 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60254321 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57817091 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57403720 |
| 53 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.53131016 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53012861 |
| 55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.51588913 |
| 56 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.51381995 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50035461 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.49439446 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46830780 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46171830 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45343741 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45039327 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38716336 |
| 64 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37819575 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35543911 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34803005 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32430891 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30569037 |
| 69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26345267 |
| 70 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.26308033 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25098463 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23857879 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22752927 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21232977 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18057088 |
| 76 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.17938923 |
| 77 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17392827 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17317481 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17233754 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16277025 |
| 81 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.16258425 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15634696 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15473728 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14846095 |
| 85 | CBP_21632823_ChIP-Seq_H3396_Human | 1.14735269 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14632766 |
| 87 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.14328633 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.14207109 |
| 89 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.13491598 |
| 90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11698371 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10196702 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09977498 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07281826 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05110171 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02047119 |
| 96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00292478 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00203606 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99838923 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99768950 |
| 100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99215788 |
| 101 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98688620 |
| 102 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97254931 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96941884 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96941884 |
| 105 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96540072 |
| 106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96198501 |
| 107 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94786178 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94096133 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94096133 |
| 110 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92964752 |
| 111 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92955864 |
| 112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92264325 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91817223 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91673209 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90772156 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90636737 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90592539 |
| 118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90547581 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89592316 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89458038 |
| 121 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89080740 |
| 122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88706263 |
| 123 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88100136 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86759280 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86286705 |
| 126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85681306 |
| 127 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85231619 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83875650 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83698164 |
| 130 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.83183711 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82244610 |
| 132 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.82208789 |
| 133 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81226740 |
| 134 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81107844 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80530398 |
| 136 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79948718 |
| 137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79773580 |
| 138 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.79312950 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77557193 |
| 140 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76948161 |
| 141 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76519812 |
| 142 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.74599463 |
| 143 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.73950758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 9.08081830 |
| 2 | * MP0005503_abnormal_tendon_morphology | 7.66195461 |
| 3 | MP0005275_abnormal_skin_tensile | 7.16500385 |
| 4 | MP0005670_abnormal_white_adipose | 6.77812874 |
| 5 | MP0005666_abnormal_adipose_tissue | 4.64114150 |
| 6 | MP0005257_abnormal_intraocular_pressure | 4.53929388 |
| 7 | MP0004130_abnormal_muscle_cell | 3.70880523 |
| 8 | MP0005375_adipose_tissue_phenotype | 3.62617183 |
| 9 | MP0003279_aneurysm | 3.56704418 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 3.37161732 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 3.21302513 |
| 12 | MP0001958_emphysema | 3.19210582 |
| 13 | MP0002971_abnormal_brown_adipose | 3.09656364 |
| 14 | MP0006054_spinal_hemorrhage | 2.91960769 |
| 15 | * MP0005508_abnormal_skeleton_morphology | 2.63932796 |
| 16 | MP0009115_abnormal_fat_cell | 2.58097547 |
| 17 | MP0009384_cardiac_valve_regurgitation | 2.51447742 |
| 18 | * MP0002108_abnormal_muscle_morphology | 2.49111639 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.33439290 |
| 20 | MP0004272_abnormal_basement_membrane | 2.32214938 |
| 21 | MP0001542_abnormal_bone_strength | 2.14779301 |
| 22 | MP0002060_abnormal_skin_morphology | 2.08911512 |
| 23 | MP0003011_delayed_dark_adaptation | 2.02062411 |
| 24 | MP0003959_abnormal_lean_body | 2.01676345 |
| 25 | MP0006138_congestive_heart_failure | 1.99406221 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.93461092 |
| 27 | MP0002295_abnormal_pulmonary_circulatio | 1.92632779 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.87118602 |
| 29 | MP0003186_abnormal_redox_activity | 1.83089205 |
| 30 | MP0002970_abnormal_white_adipose | 1.82197512 |
| 31 | MP0009250_abnormal_appendicular_skeleto | 1.80599936 |
| 32 | MP0002896_abnormal_bone_mineralization | 1.73455170 |
| 33 | MP0005334_abnormal_fat_pad | 1.67664124 |
| 34 | MP0003385_abnormal_body_wall | 1.60388865 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.56263155 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.56211691 |
| 37 | MP0002933_joint_inflammation | 1.55353858 |
| 38 | * MP0005390_skeleton_phenotype | 1.53303343 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.51674208 |
| 40 | MP0005023_abnormal_wound_healing | 1.51615458 |
| 41 | MP0004134_abnormal_chest_morphology | 1.50297582 |
| 42 | MP0003828_pulmonary_edema | 1.44558081 |
| 43 | MP0000751_myopathy | 1.43009063 |
| 44 | MP0001243_abnormal_dermal_layer | 1.42480438 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.40506527 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.37275482 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.37275482 |
| 48 | MP0005535_abnormal_body_temperature | 1.36544023 |
| 49 | MP0000163_abnormal_cartilage_morphology | 1.35967994 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.32985999 |
| 51 | MP0002115_abnormal_skeleton_extremities | 1.27920199 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.27266417 |
| 53 | MP0005448_abnormal_energy_balance | 1.25407824 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.20978044 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.17688523 |
| 56 | MP0003690_abnormal_glial_cell | 1.16153914 |
| 57 | MP0001661_extended_life_span | 1.13827626 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.12711240 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.12285221 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.12269822 |
| 61 | MP0002932_abnormal_joint_morphology | 1.12107381 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.12017890 |
| 63 | MP0000733_abnormal_muscle_development | 1.10615439 |
| 64 | MP0003091_abnormal_cell_migration | 1.08962148 |
| 65 | MP0005452_abnormal_adipose_tissue | 1.08497869 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.06940705 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.06761359 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.05896593 |
| 69 | MP0002113_abnormal_skeleton_development | 1.04389402 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.04093973 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.02516169 |
| 72 | MP0000428_abnormal_craniofacial_morphol | 1.02244777 |
| 73 | MP0003941_abnormal_skin_development | 1.01624513 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.98539706 |
| 75 | MP0000767_abnormal_smooth_muscle | 0.97216520 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 0.95348569 |
| 77 | MP0003868_abnormal_feces_composition | 0.95093385 |
| 78 | MP0002909_abnormal_adrenal_gland | 0.92053534 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.91508389 |
| 80 | MP0003283_abnormal_digestive_organ | 0.91279678 |
| 81 | MP0002109_abnormal_limb_morphology | 0.90880544 |
| 82 | MP0010630_abnormal_cardiac_muscle | 0.90211225 |
| 83 | MP0000049_abnormal_middle_ear | 0.89628598 |
| 84 | MP0003115_abnormal_respiratory_system | 0.87907710 |
| 85 | MP0009053_abnormal_anal_canal | 0.87426671 |
| 86 | MP0003755_abnormal_palate_morphology | 0.86450730 |
| 87 | * MP0005369_muscle_phenotype | 0.85893689 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.85745061 |
| 89 | MP0002168_other_aberrant_phenotype | 0.84529841 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.83949709 |
| 91 | MP0003795_abnormal_bone_structure | 0.83827195 |
| 92 | MP0005171_absent_coat_pigmentation | 0.83697741 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.83356320 |
| 94 | MP0005197_abnormal_uvea_morphology | 0.82010451 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.78002274 |
| 96 | MP0002106_abnormal_muscle_physiology | 0.78001562 |
| 97 | MP0002233_abnormal_nose_morphology | 0.76956304 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.76490986 |
| 99 | MP0005388_respiratory_system_phenotype | 0.76332192 |
| 100 | MP0002133_abnormal_respiratory_system | 0.76332192 |
| 101 | MP0003948_abnormal_gas_homeostasis | 0.76119680 |
| 102 | MP0003724_increased_susceptibility_to | 0.74448676 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73544887 |
| 104 | MP0001177_atelectasis | 0.73347854 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.71954093 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.70675583 |
| 107 | MP0002116_abnormal_craniofacial_bone | 0.70252767 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.69816629 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.69713874 |
| 110 | MP0003942_abnormal_urinary_system | 0.69246712 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.68713117 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.68683248 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.68424893 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.68319622 |
| 115 | MP0005330_cardiomyopathy | 0.68254870 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.67278960 |
| 117 | MP0002111_abnormal_tail_morphology | 0.67063158 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.66593098 |
| 119 | MP0000747_muscle_weakness | 0.65877945 |
| 120 | MP0002114_abnormal_axial_skeleton | 0.65722002 |
| 121 | MP0000432_abnormal_head_morphology | 0.64416614 |
| 122 | MP0003045_fibrosis | 0.63608379 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.62898578 |
| 124 | MP0000749_muscle_degeneration | 0.61928133 |
| 125 | MP0002128_abnormal_blood_circulation | 0.61882271 |
| 126 | MP0005193_abnormal_anterior_eye | 0.61722569 |
| 127 | MP0004484_altered_response_of | 0.61236903 |
| 128 | MP0002796_impaired_skin_barrier | 0.60102866 |
| 129 | MP0009672_abnormal_birth_weight | 0.59729759 |
| 130 | MP0003935_abnormal_craniofacial_develop | 0.59576172 |
| 131 | MP0005164_abnormal_response_to | 0.58695113 |
| 132 | MP0004883_abnormal_blood_vessel | 0.58101650 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.58071124 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.57439720 |
| 135 | MP0004145_abnormal_muscle_electrophysio | 0.56792546 |
| 136 | MP0005409_darkened_coat_color | 0.55761396 |
| 137 | MP0002177_abnormal_outer_ear | 0.55359310 |
| 138 | MP0003448_altered_tumor_morphology | 0.54999166 |
| 139 | MP0000462_abnormal_digestive_system | 0.52416544 |
| 140 | MP0010771_integument_phenotype | 0.52029464 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.51584369 |
| 142 | MP0001614_abnormal_blood_vessel | 0.51399980 |
| 143 | MP0000762_abnormal_tongue_morphology | 0.50819919 |
| 144 | MP0003122_maternal_imprinting | 0.49974544 |
| 145 | MP0001175_abnormal_lung_morphology | 0.49728137 |
| 146 | MP0003300_gastrointestinal_ulcer | 0.48907071 |
| 147 | MP0000343_altered_response_to | 0.46736636 |
| 148 | MP0005367_renal/urinary_system_phenotyp | 0.46676064 |
| 149 | MP0000516_abnormal_urinary_system | 0.46676064 |
| 150 | MP0000750_abnormal_muscle_regeneration | 0.46149843 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.45907375 |
| 152 | MP0002697_abnormal_eye_size | 0.45819982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 8.31097287 |
| 2 | Oligomenorrhea (HP:0000876) | 6.07874849 |
| 3 | Ankle contracture (HP:0006466) | 5.44037210 |
| 4 | Soft skin (HP:0000977) | 5.41267372 |
| 5 | Aortic dissection (HP:0002647) | 5.14099159 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 4.95575792 |
| 7 | Peritonitis (HP:0002586) | 4.90307261 |
| 8 | Abnormality of dentin (HP:0010299) | 4.88004970 |
| 9 | Shallow orbits (HP:0000586) | 4.86503766 |
| 10 | Biconcave vertebral bodies (HP:0004586) | 4.76411423 |
| 11 | Atrophic scars (HP:0001075) | 4.73036572 |
| 12 | Broad metatarsal (HP:0001783) | 4.71491991 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 4.60382545 |
| 14 | Neonatal short-limb short stature (HP:0008921) | 4.43986035 |
| 15 | Bladder diverticulum (HP:0000015) | 4.33457476 |
| 16 | Acanthosis nigricans (HP:0000956) | 4.26160137 |
| 17 | Genu recurvatum (HP:0002816) | 4.16002316 |
| 18 | Wormian bones (HP:0002645) | 4.14973534 |
| 19 | Vertebral compression fractures (HP:0002953) | 4.08155608 |
| 20 | Aortic aneurysm (HP:0004942) | 3.98760463 |
| 21 | Slender build (HP:0001533) | 3.94400611 |
| 22 | Hypertriglyceridemia (HP:0002155) | 3.94347891 |
| 23 | Fragile skin (HP:0001030) | 3.88973487 |
| 24 | Dilatation of the ascending aorta (HP:0005111) | 3.88902359 |
| 25 | Cervical subluxation (HP:0003308) | 3.85994179 |
| 26 | Mitral valve prolapse (HP:0001634) | 3.72506074 |
| 27 | Blue sclerae (HP:0000592) | 3.67627880 |
| 28 | Spinal rigidity (HP:0003306) | 3.64290036 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 3.61011311 |
| 30 | Cerebral aneurysm (HP:0004944) | 3.48823619 |
| 31 | Wrist flexion contracture (HP:0001239) | 3.41184481 |
| 32 | Hyperextensible skin (HP:0000974) | 3.39088171 |
| 33 | Increased connective tissue (HP:0009025) | 3.32697855 |
| 34 | Abnormal delivery (HP:0001787) | 3.22087666 |
| 35 | Breech presentation (HP:0001623) | 3.19720217 |
| 36 | Flat cornea (HP:0007720) | 3.13072268 |
| 37 | Nausea (HP:0002018) | 3.09312296 |
| 38 | Trismus (HP:0000211) | 3.06768966 |
| 39 | Round ear (HP:0100830) | 3.05908685 |
| 40 | Spondylolisthesis (HP:0003302) | 3.05547964 |
| 41 | Chin dimple (HP:0010751) | 2.96632292 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.95181431 |
| 43 | Absent phalangeal crease (HP:0006109) | 2.93774240 |
| 44 | Hip contracture (HP:0003273) | 2.91636062 |
| 45 | Bowel diverticulosis (HP:0005222) | 2.83205281 |
| 46 | Metatarsus adductus (HP:0001840) | 2.80752613 |
| 47 | Abnormality of the acetabulum (HP:0003170) | 2.77892526 |
| 48 | Joint laxity (HP:0001388) | 2.75833836 |
| 49 | Wide anterior fontanel (HP:0000260) | 2.74863608 |
| 50 | Hyperlipoproteinemia (HP:0010980) | 2.73204469 |
| 51 | Infantile muscular hypotonia (HP:0008947) | 2.72505988 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.72013069 |
| 53 | Nonimmune hydrops fetalis (HP:0001790) | 2.68480666 |
| 54 | Difficulty running (HP:0009046) | 2.66131706 |
| 55 | Broad ribs (HP:0000885) | 2.65163164 |
| 56 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.64919464 |
| 57 | Mild short stature (HP:0003502) | 2.64880654 |
| 58 | Bell-shaped thorax (HP:0001591) | 2.63572932 |
| 59 | Vascular tortuosity (HP:0004948) | 2.62707267 |
| 60 | Ectopia lentis (HP:0001083) | 2.62474808 |
| 61 | Lipoatrophy (HP:0100578) | 2.59789474 |
| 62 | Insulin resistance (HP:0000855) | 2.57375709 |
| 63 | Morphological abnormality of the middle ear (HP:0008609) | 2.56446757 |
| 64 | Elbow flexion contracture (HP:0002987) | 2.55393793 |
| 65 | Osteoarthritis (HP:0002758) | 2.55127706 |
| 66 | Prominent supraorbital ridges (HP:0000336) | 2.52144666 |
| 67 | Abnormality of the ischium (HP:0003174) | 2.48985831 |
| 68 | Overgrowth (HP:0001548) | 2.46707459 |
| 69 | Limited hip movement (HP:0008800) | 2.46682092 |
| 70 | Tibial bowing (HP:0002982) | 2.40749549 |
| 71 | Striae distensae (HP:0001065) | 2.39604968 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39336761 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.39336761 |
| 74 | Calcaneovalgus deformity (HP:0001848) | 2.37873055 |
| 75 | Decreased skull ossification (HP:0004331) | 2.35131714 |
| 76 | Femoral bowing (HP:0002980) | 2.34660349 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.32780518 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 2.30427284 |
| 79 | Lymphangioma (HP:0100764) | 2.30071958 |
| 80 | Skin nodule (HP:0200036) | 2.29832970 |
| 81 | Microglossia (HP:0000171) | 2.23866153 |
| 82 | Aortic regurgitation (HP:0001659) | 2.22991884 |
| 83 | Mitral regurgitation (HP:0001653) | 2.22638323 |
| 84 | Nemaline bodies (HP:0003798) | 2.21948037 |
| 85 | Fused cervical vertebrae (HP:0002949) | 2.21856990 |
| 86 | Deviation of the hallux (HP:0010051) | 2.19518972 |
| 87 | Hallux valgus (HP:0001822) | 2.18287720 |
| 88 | Myotonia (HP:0002486) | 2.16467127 |
| 89 | Coronal craniosynostosis (HP:0004440) | 2.15714161 |
| 90 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.14910043 |
| 91 | Thin bony cortex (HP:0002753) | 2.13985165 |
| 92 | Deformed tarsal bones (HP:0008119) | 2.13141176 |
| 93 | Malignant hyperthermia (HP:0002047) | 2.12817244 |
| 94 | Abnormality of skull ossification (HP:0002703) | 2.12499308 |
| 95 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.12239231 |
| 96 | Neck muscle weakness (HP:0000467) | 2.10369206 |
| 97 | Back pain (HP:0003418) | 2.08743794 |
| 98 | Camptodactyly of toe (HP:0001836) | 2.08028410 |
| 99 | Arterial tortuosity (HP:0005116) | 2.07870581 |
| 100 | Aneurysm (HP:0002617) | 2.07618192 |
| 101 | Asymmetry of the thorax (HP:0001555) | 2.04641987 |
| 102 | Venous insufficiency (HP:0005293) | 2.04221642 |
| 103 | Venous abnormality (HP:0002624) | 2.03304105 |
| 104 | Coxa vara (HP:0002812) | 2.02673372 |
| 105 | Osteopenia (HP:0000938) | 2.02241362 |
| 106 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02125131 |
| 107 | Myocardial infarction (HP:0001658) | 2.01755810 |
| 108 | Muscle fiber splitting (HP:0003555) | 2.01024125 |
| 109 | Gowers sign (HP:0003391) | 2.00796117 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.00588619 |
| 111 | Protrusio acetabuli (HP:0003179) | 10.4587545 |
| 112 | Spinal cord compression (HP:0002176) | 1.97844862 |
| 113 | Delayed cranial suture closure (HP:0000270) | 1.96852170 |
| 114 | Protruding ear (HP:0000411) | 1.93658251 |
| 115 | Buphthalmos (HP:0000557) | 1.93507514 |
| 116 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93269343 |
| 117 | Turricephaly (HP:0000262) | 1.91766819 |
| 118 | Subcapsular cataract (HP:0000523) | 1.91713834 |
| 119 | Bone cyst (HP:0012062) | 1.89468352 |
| 120 | Platyspondyly (HP:0000926) | 1.88305355 |
| 121 | Enlarged penis (HP:0000040) | 1.88120071 |
| 122 | Delayed epiphyseal ossification (HP:0002663) | 1.87860029 |
| 123 | Hypoplastic ischia (HP:0003175) | 1.87674926 |
| 124 | Generalized amyotrophy (HP:0003700) | 1.87590941 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.87177745 |
| 126 | Disproportionate tall stature (HP:0001519) | 1.86627208 |
| 127 | Increased muscle lipid content (HP:0009058) | 1.86287030 |
| 128 | Hypoventilation (HP:0002791) | 1.85879149 |
| 129 | Beaking of vertebral bodies (HP:0004568) | 1.84903766 |
| 130 | Inguinal hernia (HP:0000023) | 1.84431136 |
| 131 | Thin skin (HP:0000963) | 1.84343140 |
| 132 | Mesomelia (HP:0003027) | 1.83738617 |
| 133 | Popliteal pterygium (HP:0009756) | 1.82995808 |
| 134 | Syringomyelia (HP:0003396) | 1.82029828 |
| 135 | Spinal cord lesions (HP:0100561) | 1.82029828 |
| 136 | Broad long bones (HP:0005622) | 1.81311702 |
| 137 | Choanal stenosis (HP:0000452) | 1.79473049 |
| 138 | Limb-girdle muscle weakness (HP:0003325) | 1.78679812 |
| 139 | Distal arthrogryposis (HP:0005684) | 1.78225854 |
| 140 | Abnormality of the calcaneus (HP:0008364) | 1.76225358 |
| 141 | Knee flexion contracture (HP:0006380) | 1.75937669 |
| 142 | Sprengel anomaly (HP:0000912) | 1.75421462 |
| 143 | Epidermoid cyst (HP:0200040) | 1.73683766 |
| 144 | Hypophosphatemic rickets (HP:0004912) | 1.72043151 |
| 145 | Pigmentary retinal degeneration (HP:0001146) | 1.71518399 |
| 146 | Aplasia of the musculature (HP:0100854) | 1.69611155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 6.65976120 |
| 2 | SIK1 | 4.08802575 |
| 3 | PDGFRA | 3.65118884 |
| 4 | TIE1 | 3.64495841 |
| 5 | LATS2 | 3.58034687 |
| 6 | EPHA3 | 3.55550079 |
| 7 | TRIB3 | 3.51246008 |
| 8 | TTN | 3.17828554 |
| 9 | LATS1 | 2.95651088 |
| 10 | ERN1 | 2.78391761 |
| 11 | CAMK1 | 2.31629415 |
| 12 | EPHB2 | 2.29171219 |
| 13 | STK38L | 2.11017505 |
| 14 | NLK | 2.05203521 |
| 15 | RIPK1 | 2.05131462 |
| 16 | PRKAA2 | 1.98558288 |
| 17 | PAK2 | 1.87702369 |
| 18 | PAK3 | 1.69486957 |
| 19 | PKN2 | 1.66038270 |
| 20 | PIK3CA | 1.65618740 |
| 21 | PTK2B | 1.62173814 |
| 22 | FER | 1.61441487 |
| 23 | MKNK2 | 1.57748453 |
| 24 | TGFBR2 | 1.53321248 |
| 25 | OBSCN | 1.52545782 |
| 26 | PLK2 | 1.50949391 |
| 27 | PIK3CG | 1.45631418 |
| 28 | DMPK | 1.41178253 |
| 29 | PTK2 | 1.36878577 |
| 30 | MKNK1 | 1.34968194 |
| 31 | NTRK1 | 1.32504163 |
| 32 | GRK5 | 1.30715638 |
| 33 | TNIK | 1.28668975 |
| 34 | FGFR2 | 1.28260400 |
| 35 | NEK9 | 1.28214858 |
| 36 | STK16 | 1.27077510 |
| 37 | EPHB1 | 1.27017782 |
| 38 | ROCK1 | 1.17730364 |
| 39 | MET | 1.17120191 |
| 40 | LRRK2 | 1.15098999 |
| 41 | MYLK | 1.14300871 |
| 42 | FRK | 1.13024425 |
| 43 | PDPK1 | 1.12862605 |
| 44 | YES1 | 1.12123722 |
| 45 | JAK1 | 1.11910298 |
| 46 | FGFR1 | 1.11710670 |
| 47 | EPHA4 | 1.10710699 |
| 48 | PDGFRB | 1.10302411 |
| 49 | GRK1 | 1.08615060 |
| 50 | CDK9 | 1.08413289 |
| 51 | TGFBR1 | 1.07977792 |
| 52 | MAPK4 | 1.07541193 |
| 53 | ARAF | 1.06861464 |
| 54 | TRPM7 | 1.05623789 |
| 55 | LIMK1 | 1.03910605 |
| 56 | STK3 | 1.02686385 |
| 57 | EEF2K | 1.02403759 |
| 58 | ROCK2 | 1.02122071 |
| 59 | BMX | 0.97313792 |
| 60 | PTK6 | 0.95386109 |
| 61 | KSR2 | 0.91864279 |
| 62 | SCYL2 | 0.91767940 |
| 63 | CAMK1D | 0.90499236 |
| 64 | MAPKAPK3 | 0.89598230 |
| 65 | TESK1 | 0.87068010 |
| 66 | PRKG1 | 0.86371757 |
| 67 | PINK1 | 0.86102926 |
| 68 | ADRBK1 | 0.85783649 |
| 69 | STK24 | 0.85728060 |
| 70 | ERBB3 | 0.82589591 |
| 71 | PAK4 | 0.80810613 |
| 72 | MTOR | 0.74991398 |
| 73 | ILK | 0.74516860 |
| 74 | PRKCH | 0.71000844 |
| 75 | PIM2 | 0.70130556 |
| 76 | INSR | 0.69499603 |
| 77 | TTK | 0.69424392 |
| 78 | MOS | 0.68785121 |
| 79 | MAPKAPK5 | 0.68401310 |
| 80 | ERBB4 | 0.67016484 |
| 81 | NME1 | 0.66474304 |
| 82 | CDC42BPA | 0.65903676 |
| 83 | KIT | 0.65625837 |
| 84 | MAPK7 | 0.65429076 |
| 85 | PRKD1 | 0.64400735 |
| 86 | FGFR4 | 0.63592272 |
| 87 | DYRK1B | 0.63025648 |
| 88 | FLT3 | 0.62728476 |
| 89 | MST1R | 0.62646423 |
| 90 | PDK1 | 0.61694009 |
| 91 | RET | 0.61366063 |
| 92 | CLK1 | 0.59586870 |
| 93 | PRKD3 | 0.57716400 |
| 94 | PRKAA1 | 0.57437393 |
| 95 | CSF1R | 0.57104716 |
| 96 | PRKACG | 0.56143513 |
| 97 | PRKD2 | 0.55035260 |
| 98 | CDK4 | 0.54612155 |
| 99 | MAP2K1 | 0.54225073 |
| 100 | DYRK2 | 0.53616618 |
| 101 | BRAF | 0.53071782 |
| 102 | PRKACB | 0.51981935 |
| 103 | MAP3K13 | 0.51629581 |
| 104 | CAMK1G | 0.50568158 |
| 105 | FGFR3 | 0.50208813 |
| 106 | MAP3K3 | 0.49105895 |
| 107 | SRC | 0.48332495 |
| 108 | RPS6KA4 | 0.47947689 |
| 109 | ABL2 | 0.47801201 |
| 110 | PRKCE | 0.45924161 |
| 111 | PBK | 0.44649481 |
| 112 | CDK3 | 0.44210249 |
| 113 | PHKG1 | 0.43286764 |
| 114 | PHKG2 | 0.43286764 |
| 115 | GSK3A | 0.42676385 |
| 116 | BMPR1B | 0.42513656 |
| 117 | DAPK3 | 0.40490243 |
| 118 | KDR | 0.40238135 |
| 119 | PAK6 | 0.39401766 |
| 120 | EIF2AK3 | 0.39377021 |
| 121 | CDC7 | 0.38271512 |
| 122 | PRKACA | 0.37450427 |
| 123 | VRK2 | 0.36657070 |
| 124 | LMTK2 | 0.34023506 |
| 125 | ABL1 | 0.33019111 |
| 126 | CSK | 0.31832547 |
| 127 | EIF2AK2 | 0.31315052 |
| 128 | AKT2 | 0.31155477 |
| 129 | RPS6KA3 | 0.30990847 |
| 130 | CDK8 | 0.30914502 |
| 131 | MARK2 | 0.29405282 |
| 132 | FYN | 0.28620251 |
| 133 | MAP3K7 | 0.28617159 |
| 134 | CDK6 | 0.28185040 |
| 135 | ERBB2 | 0.27397558 |
| 136 | MAP2K3 | 0.26856324 |
| 137 | CAMKK1 | 0.25532523 |
| 138 | PRKCG | 0.25427599 |
| 139 | MAPK1 | 0.24890590 |
| 140 | MAPK12 | 0.24752266 |
| 141 | PAK1 | 0.22393427 |
| 142 | PRKG2 | 0.22365069 |
| 143 | CDK14 | 0.22122528 |
| 144 | CHUK | 0.22055682 |
| 145 | IGF1R | 0.21404404 |
| 146 | PKN1 | 0.20373399 |
| 147 | MAP3K6 | 0.20314936 |
| 148 | JAK2 | 0.19861076 |
| 149 | TAOK2 | 0.19379104 |
| 150 | CAMKK2 | 0.17856519 |
| 151 | TAOK1 | 0.17200308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 5.61931919 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.23986880 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.67470915 |
| 4 | Focal adhesion_Homo sapiens_hsa04510 | 3.49746389 |
| 5 | Malaria_Homo sapiens_hsa05144 | 3.32822899 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.04255558 |
| 7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.92886601 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.73485005 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.70191153 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.68897587 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53141675 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51172590 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47950066 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.35003074 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 2.33076694 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.31490532 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.30603818 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27895330 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.26448810 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.15924988 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.12778977 |
| 22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.11737972 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11267252 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97006346 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.96138023 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.91729207 |
| 27 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.88556712 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.82000236 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.79000388 |
| 30 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.72662798 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.68696115 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67033185 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65752314 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.63720738 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.62029277 |
| 36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.52834614 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.52803467 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47739963 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.46969517 |
| 40 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.46420417 |
| 41 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.42202992 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40740160 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.32437721 |
| 44 | Melanoma_Homo sapiens_hsa05218 | 1.31901725 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.28373798 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.27580549 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.25181025 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.21574897 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18915565 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.15501421 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.13285822 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.10154819 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09482951 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07558365 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03487771 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.00177753 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00016535 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97849974 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95215023 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93637656 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.93397767 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.92298371 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90867819 |
| 64 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.90211791 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89933692 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89337861 |
| 67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88093858 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86282584 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.85090377 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83685377 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83630792 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83021570 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81922145 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81524937 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81109618 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79517517 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79156478 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78514622 |
| 79 | Proteasome_Homo sapiens_hsa03050 | 0.78040526 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77624146 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77284929 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77247346 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76362430 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.73867180 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73543419 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73091522 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72145727 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.72055934 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71977933 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.71132332 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70783545 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70551321 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68543590 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68244678 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67038455 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66966985 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63617795 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.63152129 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62920590 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62871392 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.62828879 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62505093 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61295372 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59893050 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59671813 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59253576 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58741919 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58539326 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58295809 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58209384 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56856013 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56340252 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55393803 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55227858 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54918378 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53488862 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52741943 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50873814 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49353501 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48976184 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.48640718 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48509198 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48142047 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48114034 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47398049 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.47123018 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46378416 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45971202 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45809583 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45567897 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44719583 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.42659362 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42568610 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41780579 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41765022 |
| 136 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41753969 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41406389 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.41172461 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40878801 |
| 140 | Lysosome_Homo sapiens_hsa04142 | 0.40582973 |
| 141 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40200574 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39624176 |
| 143 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39577961 |
| 144 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39418718 |
| 145 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39046830 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38668432 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38383008 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38196285 |
| 149 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37648646 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.37350242 |
| 151 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37049808 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36879652 |
| 153 | Salmonella infection_Homo sapiens_hsa05132 | 0.36823882 |
| 154 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35633979 |
| 155 | Bile secretion_Homo sapiens_hsa04976 | 0.33726561 |
| 156 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31745958 |
| 157 | Ribosome_Homo sapiens_hsa03010 | 0.28468643 |
| 158 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25978240 |
| 159 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20814930 |
| 160 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18947445 |

